vs

Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Victory Capital Holdings, Inc. (VCTR). Click either name above to swap in a different company.

Victory Capital Holdings, Inc. is the larger business by last-quarter revenue ($374.1M vs $270.8M, roughly 1.4× HUTCHMED (China) Ltd). Victory Capital Holdings, Inc. runs the higher net margin — 30.2% vs 0.7%, a 29.4% gap on every dollar of revenue. On growth, Victory Capital Holdings, Inc. posted the faster year-over-year revenue change (61.0% vs -16.5%). Victory Capital Holdings, Inc. produced more free cash flow last quarter ($144.5M vs $3.4M).

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

Victory Capital Holdings, Inc. is an American financial services company headquartered in San Antonio, Texas that focuses on investment management. Outside the US, it also has investment professionals in London, Hong Kong and Singapore.

HCM vs VCTR — Head-to-Head

Bigger by revenue
VCTR
VCTR
1.4× larger
VCTR
$374.1M
$270.8M
HCM
Growing faster (revenue YoY)
VCTR
VCTR
+77.5% gap
VCTR
61.0%
-16.5%
HCM
Higher net margin
VCTR
VCTR
29.4% more per $
VCTR
30.2%
0.7%
HCM
More free cash flow
VCTR
VCTR
$141.1M more FCF
VCTR
$144.5M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HCM
HCM
VCTR
VCTR
Revenue
$270.8M
$374.1M
Net Profit
$2.0M
$112.8M
Gross Margin
37.7%
Operating Margin
-13.2%
40.9%
Net Margin
0.7%
30.2%
Revenue YoY
-16.5%
61.0%
Net Profit YoY
-83.6%
46.6%
EPS (diluted)
$0.00
$1.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCM
HCM
VCTR
VCTR
Q4 25
$270.8M
$374.1M
Q3 25
$361.2M
Q2 25
$277.7M
$351.2M
Q1 25
$324.5M
$219.6M
Q4 24
$232.4M
Q3 24
$225.6M
Q2 24
$305.7M
$219.6M
Q1 24
$215.9M
Net Profit
HCM
HCM
VCTR
VCTR
Q4 25
$2.0M
$112.8M
Q3 25
$96.5M
Q2 25
$455.0M
$58.7M
Q1 25
$11.9M
$62.0M
Q4 24
$76.9M
Q3 24
$82.0M
Q2 24
$25.8M
$74.3M
Q1 24
$55.7M
Gross Margin
HCM
HCM
VCTR
VCTR
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Q1 24
Operating Margin
HCM
HCM
VCTR
VCTR
Q4 25
-13.2%
40.9%
Q3 25
38.2%
Q2 25
-1.3%
26.8%
Q1 25
-5.0%
42.3%
Q4 24
48.1%
Q3 24
53.3%
Q2 24
-9.0%
50.4%
Q1 24
39.3%
Net Margin
HCM
HCM
VCTR
VCTR
Q4 25
0.7%
30.2%
Q3 25
26.7%
Q2 25
163.8%
16.7%
Q1 25
3.7%
28.2%
Q4 24
33.1%
Q3 24
36.3%
Q2 24
8.4%
33.8%
Q1 24
25.8%
EPS (diluted)
HCM
HCM
VCTR
VCTR
Q4 25
$0.00
$1.33
Q3 25
$1.11
Q2 25
$0.52
$0.68
Q1 25
$0.01
$0.96
Q4 24
$1.18
Q3 24
$1.24
Q2 24
$0.03
$1.12
Q1 24
$0.84

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCM
HCM
VCTR
VCTR
Cash + ST InvestmentsLiquidity on hand
$1.4B
$163.7M
Total DebtLower is stronger
$93.2M
$970.0M
Stockholders' EquityBook value
$1.2B
$2.4B
Total Assets
$1.8B
$4.2B
Debt / EquityLower = less leverage
0.08×
0.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCM
HCM
VCTR
VCTR
Q4 25
$1.4B
$163.7M
Q3 25
$115.7M
Q2 25
$1.4B
$107.9M
Q1 25
$836.1M
$175.6M
Q4 24
$126.7M
Q3 24
$188.2M
Q2 24
$802.5M
$119.0M
Q1 24
$79.9M
Total Debt
HCM
HCM
VCTR
VCTR
Q4 25
$93.2M
$970.0M
Q3 25
$972.0M
Q2 25
$93.4M
$965.7M
Q1 25
$82.8M
$964.8M
Q4 24
$963.9M
Q3 24
$982.7M
Q2 24
$82.1M
$981.7M
Q1 24
$990.2M
Stockholders' Equity
HCM
HCM
VCTR
VCTR
Q4 25
$1.2B
$2.4B
Q3 25
$2.4B
Q2 25
$1.2B
$2.5B
Q1 25
$759.9M
$1.1B
Q4 24
$1.1B
Q3 24
$1.2B
Q2 24
$740.1M
$1.1B
Q1 24
$1.1B
Total Assets
HCM
HCM
VCTR
VCTR
Q4 25
$1.8B
$4.2B
Q3 25
$4.2B
Q2 25
$1.8B
$4.2B
Q1 25
$1.3B
$2.6B
Q4 24
$2.5B
Q3 24
$2.6B
Q2 24
$1.3B
$2.5B
Q1 24
$2.5B
Debt / Equity
HCM
HCM
VCTR
VCTR
Q4 25
0.08×
0.40×
Q3 25
0.41×
Q2 25
0.08×
0.39×
Q1 25
0.11×
0.84×
Q4 24
0.86×
Q3 24
0.84×
Q2 24
0.11×
0.87×
Q1 24
0.92×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCM
HCM
VCTR
VCTR
Operating Cash FlowLast quarter
$8.2M
$145.1M
Free Cash FlowOCF − Capex
$3.4M
$144.5M
FCF MarginFCF / Revenue
1.2%
38.6%
Capex IntensityCapex / Revenue
1.8%
0.2%
Cash ConversionOCF / Net Profit
4.21×
1.29×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M
$381.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCM
HCM
VCTR
VCTR
Q4 25
$8.2M
$145.1M
Q3 25
$165.9M
Q2 25
$-72.9M
$-6.6M
Q1 25
$40.3M
$81.1M
Q4 24
$91.8M
Q3 24
$99.8M
Q2 24
$-39.8M
$79.7M
Q1 24
$68.7M
Free Cash Flow
HCM
HCM
VCTR
VCTR
Q4 25
$3.4M
$144.5M
Q3 25
$164.8M
Q2 25
$-82.2M
$-7.5M
Q1 25
$32.5M
$79.5M
Q4 24
$91.7M
Q3 24
$99.4M
Q2 24
$-49.9M
$79.5M
Q1 24
$68.2M
FCF Margin
HCM
HCM
VCTR
VCTR
Q4 25
1.2%
38.6%
Q3 25
45.6%
Q2 25
-29.6%
-2.1%
Q1 25
10.0%
36.2%
Q4 24
39.4%
Q3 24
44.0%
Q2 24
-16.3%
36.2%
Q1 24
31.6%
Capex Intensity
HCM
HCM
VCTR
VCTR
Q4 25
1.8%
0.2%
Q3 25
0.3%
Q2 25
3.3%
0.3%
Q1 25
2.4%
0.7%
Q4 24
0.1%
Q3 24
0.2%
Q2 24
3.3%
0.1%
Q1 24
0.2%
Cash Conversion
HCM
HCM
VCTR
VCTR
Q4 25
4.21×
1.29×
Q3 25
1.72×
Q2 25
-0.16×
-0.11×
Q1 25
3.38×
1.31×
Q4 24
1.19×
Q3 24
1.22×
Q2 24
-1.54×
1.07×
Q1 24
1.23×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HCM
HCM

Segment breakdown not available.

VCTR
VCTR

Investment Management Fees$301.4M81%
Fund Administration And Distribution Fees$72.8M19%

Related Comparisons